chrisvoncsefalvay/vaers-outcomes huggingface dataset:
During vaccination patient started to have a seizure about half way through the injection and fainted. Seizure only last roughly 10 seconds, but took the pt roughly a min to regain consciousness.
Within 1 minute of being given injection, patient reported feeling light headed, and nauseated. Patient started clutching chest, and dry heaved several times. Patient was given 16oz orange juice, and rested for 10 minutes. The patient reported they felt fine after the rest, and left the facility under their own power.
Same night as injection patient stated arm was sore and warm to touch. She left town early the next day (11/23) and went to Urgent Care. Patient states "arm mushroomed quickly" & Dr at urgent care could feel swelling and heat of arm through a sweater and coat. Arm was swollen from top of shoulder to elbow. She stated her symptoms were: itchy, hot, red, swollen, couldn't touch. Urgent care did cold compress, gave BENADRYL. Urgent care offered a steroid which she declined to receive. She did cold compress and BENADRYL for 3 & 1/2 days after her urgent care visit till the heat and swelling subdued.
Woke up with charley horse in left calf. Muscle twitching with no pain mostly in both calves. When body was fully relaxed felt muscle twitching in triceps, lats, lower quads, and in thighs. Twitching amount has remained about the same now about a week later. Some muscle straining and cramping, general feeling of tightness throughout legs felt when standing.
Pt was diagnosed with Rotavirus by urgent care. Diarrhea since 03/28/13 with dehydration. Baby sitter stated she had kept another child with rotavirus.
Feeling feverish without actual fever, headache, body aches, sneezing, malaise
Receives dose #1 of the covid vaccine and contracts covid prior to dose #2; Receives dose #1 of the covid vaccine and contracts covid prior to dose #2; This is a spontaneous report from a contactable physician via Pfizer sales representative. This physician reported similar events for two patients. This is 2nd of two reports.   A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient received dose #1 of the COVID vaccine and contracts COVID prior to dose #2 on an unspecified date. The patient underwent lab test which included Covid-19 test in which he/she tested positive on an unknown date. Outcome of the events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : US-PFIZER INC-2021012928 Same reporter/drug/event, different patient
12 hours after the vaccination, I was fatigued. And my thighs began to hurt massively; It was hard to walk. Thighs, muscles, shins and calves.
So right after getting the shot, within an hour, he complained of a pain in his back and I thought it was left over from the arm pain from the shot. But then he complained of stomach ache as well. We went to the hospital in June and they have done so many tests on him though and he was referred to a GI DR as well. He gets a stomach ache after having full meals, like anything normal size he used to eat, he gets nausea. He passes stool that is yellow in color. The DRs are still working on him currently though. He has some sort of bug or something. We have tried Pepto bismol and other over the counter medications but they have not helped.
myocarditis/pericarditis - shortness of breath, heart palipations, chest pains ongoing for multiple weeks
PATIENT CALLED OFFICE 2 DAYS AFTER RECEIVING VACCINE COMPLAINING OF SWELLING THAT STARTED ON PREVIOUS DAY. PATIENT SEEN BY MD IN OFFICE. RASH, WHICH STARTED ON LEFT UPPER ARM HAD GRADUALLY WORSENED AND SPREAD TO ELBOW. MD NOTED RASH TO BE CHARACTERIZED BY SWELLING, REDNESS, AND PAIN (JOINT PAIN). PATIENT WITH NO OTHER SYMPTOMS. PATIENT TREATED WITH RANITIDINE 150MG BID, CETIRIZINE 10MG DAILY, AND DIPHENHYDRAMINE 25-50MG AT BEDTIME FOR 1 WEEK.
Rash, UrticariaPruritus, itchy red, raised rash at injection site, returned 1/8 rash seemingly resolved but area of redness has expanded, still warm, firmer than previous day.
FEVER; TIREDNESS; This spontaneous report received from a patient via a company representative concerned an adult male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced fever, and tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and tiredness was not reported. This report was non-serious.
Arm became red/firm/swollen - lg area of redness. Discomfort x 2-4 days. Mom treated with OTC pain reliever, rest and bathing.
Inappropriate Reconstitution Technique; Inappropriate dose of vaccine administered; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 3FD3N, expiry date 9th July 2021) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows:  The age at vaccination was not reported. The nurse on the line who reported another nurse was preparing the vaccine and got distracted and just administered the diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  Follow up information received from nurse on 15th May 2019: the patient received Shingrix via intramuscularly. The patient was notified and follow up resulted in no known harm to patient. It was medication error without harm.
Flushed checks on face, vaccination arm had 3" wide red band around said arm - for approximately one week. Pain occurred during that time with swollen arm and cheeks.
Event: Left arm injection site pain was reported as worsened; had swelling in both temples; Tension headache; Left arm injection site pain; This is a spontaneous report from a contactable consumer (patient himself). A 49-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EM9809), via intramuscular route, administered in left arm on 11Feb2021 09:00 (age at vaccination: 49 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included joint infection on his right elbow from a surgery that he had in 2020, which was in a different arm than injection. This is why he is taking the Penicillin VK and oral herpes. Concomitant medication(s) included phenoxymethylpenicillin potassium (PENICILLIN VK), 500 mg three times daily taken for arthritis infective from 05Jan2021; valaciclovir hydrochloride 2 grams every 12 hours by mouth as needed taken for oral herpes. The patient started valaciclovir hydrochloride 5 years ago. He took two doses the night before he received the vaccine. Finished it the morning of 11Feb2021. The patient received the vaccination in Health Department. On 11Feb2021 17:30, the patient experienced had swelling in both temples. On 11Feb2021, the patient had tension headache, left arm injection site pain, left arm injection site pain was reported as worsened. The tension headache got worse and it was just off and on. It felt like overworked muscles. The patient did not require emergency room or physician's office visit's urgent care to look at swelling. No medical treatment was received and was advised to go to the ER if it got worse. The patient did not receive any prior vaccination in 4 weeks. On an unknown date in 2020, the patient underwent investigation (unspecified) which was looking good. He was considered a high risk patient. The outcome of the swelling face was recovering, condition aggravated was unknown and all the other events were unknown. There was no product quality complaint present.  Follow-up attempts completed. No further information expected.
Pt recv vax on 2/23/98; on 3/1/98 pt exp itching x 10dy & rash x 7 dy on legs & wrists; 3/2/98 pt exp rash over entire body; tx=Prednisone & unknown cream
Site Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Site Tenderness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SIMVASTATIN for Cholesterol, HCTZ for Hypertension, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Site Tenderness). On 20-Jan-2021, VACCINATION SITE PAIN (Site Tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-030892 (Patient Link).
Pt began to feel dizzy and light-headed with progressing headache pain within 15 minutes. Pt BP was 170/86 at time of event and HR 74 bpm. Pt given O2 at 5 LPM . Pt lungs clear bilaterally and pt denied SOB. Pt O2 saturation at 99% on 5 LPM via mask.  Pt stated vision was blurry but resolved after 15 minutes. Pt advised to go to ER via ambulance but denied transport, pt wife at facility to transport pt to ER.
A week after injection, I developed a large area of itchy rash, ranging more than half way down my right upper arm from the injection site.  It is extremely itchy, similar to the cases of large hive welts I experienced as a teenager in the 1970s.
injection site reaction, redness; injection site swollen; injection site pain; upper back pain; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number D9cb9, expiry date 24th September 2023) for prophylaxis.   On 24th January 2023, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th January 2023, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site swelling, injection site pain and upper back pain. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site pain were not recovered/not resolved and the outcome of the upper back pain was recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site pain and upper back pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-JAN-2023 Reporter's Comment: The case was self reported by the patient. The patient received first dose of Shingrix into left arm and just a little while following getting the vaccine, she started having upper back pain and an injection site reaction such as redness, swollen and pain. The patient reported that she was still experiencing these symptoms. The reporter consented to follow up. Additional Supportive Information: Event outcome for upper back pain was kept as recovered as reported in structured field and clarification raised for the same.
Pt recvd 1 doses of Engerix-B & 3JUN92 began to lose vision in rt eye; 10JUN92 had light perception only in rt eye; Reporter indicated these sx are consistent w/optic neuritis; seen by MD; no improvement;
I was in bed and I felt paralyzed for 3 days. I could not shower and I'm still sore but in my right armpit area and I got the shot in my left arm.
The night after I was vaccinated, I awoke multiple times desperately gasping for air. I do not have apnea or anything like that; it was from the booster shot.  I was feeling progressively worse and worse and by about 6 AM on the 24th of December, I began vomiting more violently than is typical for me when sick. I was drifting in and out of consciousness throughout the morning, only to be awaken by the same gasping for air, except now the gasping was accompanied by a severe need to vomit.  By the evening the vomiting had subsided but I was still extremely nauseous, occasionally out of breath for no reason, and feeling very exhausted.   I did not get out of bed for two days except to vomit, refill my water,  and use the facilities. For two weeks days after the booster shot I was overcome with moderately severe depression.  My body was inflamed for three weeks, with my rings difficult to remove from my fingers. I had a migraine for a week straight after receiving the booster.  It is by far the most sick I have ever been after receiving any type of vaccination.   Oddly enough, the booster left my arm feeling sore for much less time than the first two shots did. But everything else aside from my arm was much, much worse with the booster.   If I had not already been on vacation, I would have missed at least four days of work due to how sick I was from the booster.  The only lingering symptoms I have as of Jan 15, 2020 are very mild global inflammation and depression (more than I normally have)   For this reason, I answered "unknown" for question #20  The side effects I experienced were alarming enough that  I would have gone to the ER under normal circumstances, but I did not go because the hospitals are overwhelmed with covid patients right now.   I did mention the symptoms to the physician's assistant last time I was seen though.
Right upper arm red swollen, warmth to touch, and tender touch measuring around 3.5 inches x 2 inches which occurred 48 hours post vaccination.
Anxiety; pain from top back of his head to bottom of neck; pain from top back of his head to bottom of neck; This is a spontaneous report from a contactable consumer (Patient) or other non HCP.  A 71-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9266, expiration date: May2021), via an unspecified route of administration in arm left on 22Feb2021 (at the age of 71-years-old) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. Historical vaccine included the first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number unknown), via an unspecified route of administration on an unspecified anatomical location on unspecified date as dose 1, single for covid-19 immunisation. On an unknown date, the patient experienced anxiety. on 23Sep2021, after 1 day vaccination the patient experienced pain from top back of his head to bottom of neck. Consumer reported that he had some effects after he had his last shot which he got last on the 22Feb. He says that the day after he had reaction to it where the top of the back of his head to the bottom of his neck felt like someone hit him like something real hard. He said that the second dose also altered his nerves, meaning anxiety, quite a bit. He said that he did not have the pain to the top of his head down to the bottom of his neck before getting the second dose, it was new. Patient received treatment for event back of his head down to the bottom of his neck pain for treatment Tylenol two to three days after that. The outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
left deltoid rash, swelling, warmth, started 8 days after vaccination.  seen 1/26/2021, resolved by 1/29/2021
Initial report received from a health care professional (nurse) on 20 Sep 2010: This patient was vaccinated with only the MenCWY liquid conjugate component of MENVEO (batch no 090701) at an unspecified dose intramuscularly on 17 Sep 2010. No adverse events were noted following this medication error.
Strong ache/pain  in shoulder neck and both arms and hands. Tired feeling and stomach upset.
poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cough. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH (poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.). The patient was treated with METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Symptomatic treatment, at an unspecified dose and frequency and CLOBETASOL (topical) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, RASH (poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.) had not resolved.            Concomitant medications also included Cough drops as needed.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-JUL-2021 contains no new information.
This case was reported by a nurse and described the occurrence of petechial rash in a 2-month-old pt who received diptheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix) for prophylaxis. Concurrent vaccines/medications, concurrent medical conditions and medical history were not provided. On an unknown date, the pt received the 2nd dose of Pediarix (lot 21882B2). On an unspecified date post-immunization, the pt experienced a petechial rash on the lower legs which spread to the arms. The event was unresolved as of 10/03/2003.
I was walking in the store, and I had to sit down before we got to the back of the store. I got a headache, fatigue, upset stomach, phlegmy cough, and nausea. I tested positive for COVID-19 at home. By the 12th I had a fever of 105 and I went to the doctor. They told me to take vitamin D3, vitamin C, zinc, benzonatate and TYLENOL PM. My fever went down to 104 for two days. I still have fatigue and feel bad.
1410 Client became light headed and reported to obs desk.  Unassisted descent to floor upon turning to go to a 30 min obs seat. Did not strike head, sat on buttocks and propped self with left arm; No medical Hx. BP 140/100  P 96  R 12 SpO2 100%; LOC A&O x3, did not lose consciousness; skin warm pink and sweaty; hot at back of neck; HR regular; Resps unlabored; Lungs clear; assisted to a supine on floor and legs elevated; ice pack for comfort; EMS notified 1420  BP 152/104  P 70  R 12 SpO2 99% Resps continued unlabored; EMS arrived; Handoff report given; EMS assessed; client sitting; ; client offered transport to local ED and declined 1430 Client moved back into chair; BP 136/94  P 94  R 12 SpO2 99% 1440  Client stated she was starting to feel light headed again.  Moved to floor and legs elevated again.  BP 140/90  P 87  R10; Resps unlabored; A&O x3; skin cool pink dry;  1445  BP 136/108  P 85  R 10 ; continues supine with legs elevated; requested that client find someone to drive her home rather than drive self; client contacting boyfriend 1450 BP 140/108  Client states she feels fine but would like to remain on the floor sitting up. 1500 Client moved to chair for further observation; VS assessment discontinued 1530 Client remains in obs and waiting for ride
[Moderna vaccine] use for COVID-19 UNDER Emergency Use Authorization (EUA): The patient received her booster on 10/30/21. Her prior shots were on Jan 09 and Feb 06, both Moderna. She started experiencing palpitations the same night. Symptoms continued unremitting and she consulted me on 11/05/21. EKG was normal as was the blood work. She was advised to continue home monitoring with EKG machine which documented monomorphic VPCs. An echocardiogram performed the same day was ABNORMAL and showed a moderate pericardial effusion without evidence of Tamponade. Patient was treated medically with Naprosyn 440 mg PO BID. As of today she had taken Naprosyn for 5 days. Today, palpitations are reported to be 80% better and repeat echo shows a significant reduction in pericardial effusion. Additional blood work including ESR, CRP, ANA, anti-DS DNA and Quantiferon studies is being done today. Patient will return to the office in one week for a repeat echo
My symptoms a severe sore throat, a moderate fever, severe fatigue, and loss of appetite. I was prescribed a five-day regimen of Paxlovid on March 22, 2023. I had a rebound case of COVID-19 after I finished taking Paxlovid. On March 29, 2023, I tested negative. On April 1, 2023, I had severe sinus pressure, congestion, fatigue, and loss of appetite. On April 2, 2023, I tested positive again. On April 7, 2023, I tested negative.
A report was received from a consumer concerning a 53 year old male vaccine who inadvertently received 1ml Fluvirin on 10/30/02. The vaccinee experienced no adverse reaction.
pt recv vax 2SEP97 & evening of 3SEP97 found by parents to be incontinent & w/ thick white foam in mouth shivering too but no observed tonic clonic movement;would arouse verbally & physically responded;
Patient was given a different primary series vaccine. Patient originally received Moderna as their first dose and received Pfizer as their second. No treatment was given. Patient's mother was advised per CDC protocols to return for a 3rd dose of either Moderna or Pfizer 8 weeks from the second dose. Patient was observed for 15 minutes and experienced no adverse effects. Mother reported child to be fine and left with child after observation time was complete.